Metformini hydrochloridum
| Medicinal product name | Glucophage XR 500 mg extended release tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Prolonged-release tablet | ||||||
| Strength | 500 mg | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Next lowest cost medicine |
||||||
| Package leaflet |  12-07-2022
|
||||||
| Summary of product characteristics |  27-10-2022
|
||||||
| ATC code | A10BA02 – Drugs used in diabetes | ||||||
| Information for Marketing authorisation holders | View |
Important notice
Additional information regarding the use for persons aged 75+
| If used as "DRUGS USED IN DIABETES" | ||
|---|---|---|
| Substance | Class | Comment |
| Metformini hydrochloridum | C | Suitable for older adults, with specific precautions. Reduce the dose already in mild renal impairment. Do not use in severe renal impairment or tissue hypoxia. May reduce the absorption of vitamin B12. Consider risk of lactic acidosis. The drug should be paused during fever, gastroenteritis or dehydration, and before surgery or imaging with a contrast agent. |
Medicinal products (2)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Is available (according to the information provided by wholesalers) (22905 containers) |
Merck Serono, Tamro, Recipe Plus, Magnum Medical, Saules aptieka, Euroaptieka, Jelgavfarm, Oribalt Rīga |
N30 (500 mg) |
PVC/PVDC/Al blister |
€ 4.50 * |
04-0289-01 |
Labelling text Mar 10, 2022 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (500 mg) |
PVC/PVDC/Al blister | 04-0289-02 |
Labelling text Mar 10, 2022 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 04-0289 |
|---|---|
| Date of authorisation | Apr 29, 2004 |
| Marketing authorisation holder, country | Merck Sante s.a.s., France |
